Krsnaa Diagnostics Limited — Important, 12-02-2025: Updates

The Board of Directors of Krsnaa Diagnostics Limited has approved a revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI). This code aims to enhance compliance with the Securities and Exchange Board of India (SEBI) regulations concerning insider trading. It provides a structured approach for the company to handle and disclose UPSI, ensuring that all material information is communicated uniformly and transparently to stakeholders. Noteworthy components include measures for maintaining the confidentiality of UPSI, protocols for trading in securities when equipped with such information, and provisions for pre-clearance of trades by designated personnel. The updated code underscores the importance of adherence to legal standards while reinforcing the company's commitment to fair practices in financial reporting and disclosure. Shareholders should observe how these changes may impact governance practices and overall company transparency.